Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Biopsy Breast Modified Radical Mastectomy

A diagnostic test examining breast tissue obtained during a modified radical mastectomy to detect cancer or other abnormalities.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Breast tissue sample obtained during modified radical mastectomy surgery.
Results
Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required for the analysis of the tissue sample itself. However, preparation for the surgical procedure (modified radical mastectomy) will be guided by your surgeon.
Test priceKSh 9,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Biopsy Breast Modified Radical Mastectomy test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Presence of breast lumps or masses
  • ✓Changes in breast shape or size
  • ✓Nipple discharge or inversion
  • ✓Abnormal findings on imaging (e.g., mammogram)
  • ✓Family history of breast cancer
  • ✓Evaluation of breast tissue removed during modified radical mastectomy surgery
02

In plain language

What this test helps you understand

Diagnosis of breast cancer, determination of tumor type and characteristics, guiding treatment decisions.
The Biopsy Breast Modified Radical Mastectomy is a specialized diagnostic procedure used to examine breast tissue removed during surgery. This test is crucial for identifying cancerous cells or other abnormalities within the breast tissue. It plays a vital role in the diagnosis and management of breast cancer, helping healthcare professionals determine the appropriate course of treatment and improve patient outcomes.

This biopsy test analyzes the tissue sample to detect abnormal cellular changes, specifically looking for malignant (cancerous) cells. It also helps assess the characteristics of any tumor found, which is essential for determining the stage and type of breast cancer, if present.

Understanding Your Results

After the biopsy, results are typically available within 6 days. Your healthcare provider will discuss the findings with you, explaining whether cancerous cells were detected and the implications for your health. Understanding these results is crucial for planning your next steps in treatment.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required for the analysis of the tissue sample itself. However, preparation for the surgical procedure (modified radical mastectomy) will be guided by your surgeon.
SampleBreast tissue sample obtained during modified radical mastectomy surgery.
MethodologyHistopathological examination of tissue sections stained with special dyes under a microscope.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes the tissue sample provided. The accuracy depends on the quality and representativeness of the sample. It does not provide information about cancer spread beyond the sampled tissue.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

A modified radical mastectomy is a surgical procedure to remove breast cancer, typically involving the removal of the entire breast, lymph nodes under the arm, and sometimes the chest wall muscles.
A biopsy of the removed tissue is essential to confirm the presence of cancer, determine its exact type, grade, and whether it has spread to lymph nodes, which helps plan further treatment.
Results are typically available within 6 days, but confirm the exact turnaround time with the laboratory before booking.
Your doctor will discuss the biopsy results with you, explaining the findings and recommending the next steps in your care, which may include further treatment.
The biopsy analysis itself is not painful as it is performed on tissue already removed. Pain is associated with the surgical procedure (mastectomy), which your surgical team will manage.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp